sars situation in guangdong and hospital infection control xiaoping tang, m.d, ph.d guangzhou no. 8...
Post on 18-Dec-2015
213 Views
Preview:
TRANSCRIPT
SARS Situation in GuangdongSARS Situation in Guangdong and Hospital Infection Control and Hospital Infection Control
Xiaoping Tang, M.D, Ph.D
Guangzhou No. 8 People’s Hospital
Number Of SARS Patients and HCW Infection (AS of 8/7/2003) Cases Death (%) HCW(%) Last Report
Global 8422 916 11 1725(20) 7.13
China(Main) 5327 349 7 1002(19) 6.25
Guangdong 1512 58 4 346(23) 6.25
Hongkong 1755 300 17 386(22) 5.31
Taiwan 665 180 27 86(13) 6.15Canada 251 41 17 108(43) 6.12Singapore 283 33 14 97(41) 5.05
Foshan Cases
In November, 2002 A cluster of 5 cases of
Pneumonia from one family were hospitalized, 2 developed to RF
( First case : onset time Nov 16 )
Large shadows in Lungs No Response to
Antibiotics X-Ray
Heyuan Cases
• Mr. Huang, a restaurant cook, got sick on Dec.10 in Shenzhen
• admitted to Heyuan 1st Hospital on Dec.15, 2002
• A cluster of cases including 8 HCW happened
First case in Heyuan
Zhongshan Cases
• January 20, 20 cases were reported to Guangdong Health Bureau.
• Jan. 21, experts from Guangzhou, Foshan, Heyuan and China CDC had consultation together.
Total Patients Received
• 1st patients: Feb 2, 2003
• Total : 413 probable & suspect cases
(262 confirmed )
Male 124
Female 138
Age 2-89 years old
average 41±18
SARS contacting history 175 (67.3%)
Incubation period 1-14 d
average 4.5 d
General Information
Clinical features (%) Hong KongLee et al(n=138)
TorontoBooth et al (n=144)
Hong KongPeiris et al
(n=50)
GuangzhouZhang et al
(n=260)
SingaporeHsu et al
(n=20)
Fever 100 99.3 100 100 100
Chills/rigor 73.2 27.8 74 51.2 15
Myalgia 60.9 49.3 54 26.5 45
Cough 57.3 69.4 62 72.7 75
Dyspnoea -- 41.7 20 75.4 40
Headache 55.8 35.4 20 26.5 20
Dizziness 42.8 4.2 12 46.5 --
Sputum 29.0 4.9 -- 11.5 --
Diarrhoea 19.6 23.6 10 24.2 25
Nausea & vomiting 19.6 19.4 20 -- 35
Sore throat 23.2 12.5 20 -- 25
Malaise -- 31.2 50 24.6 45
Presenting Symptoms
Laboratory Findings (1)
Leucocyte >10 ×109/L 38 (14.6%)
4.0~10 ×109/L 146 (56.2%)
< 4.0 ×109/L 76 (29.2%)
< 2.0 ×109/L 35 (13.5%)
Lymphocyte < 1.5 ×109/L 226 (86.9%)
Platelet < 10 ×109/L 25 (9%)
the lowest 2.5 ×109/L
Laboratory Findings (2)
LDH increase 121 (46.5%)
CK increase 106 (40.8%)
ALT increase 174 (66.9%)
AST increase 136 (52.3%)
BUN 28 (10.8%)
CD4 + lymphocyte 475.6 ± 405.2/ul
< 400/ul 56/93 (60.2%)
< 200/ul 30/93 (32.3%)
the lowest 23/ul
SO2 < 95% 101 (38.8%)
Laboratory Findings (3)Laboratory Findings (3)
1527
787633
954
551
371472
244 202
0
200
400
600
800
1000
1200
1400
1600
1800
2000
2200
CD3+ CD4+ CD8+
Normal
Mild
Severe
T Lymphocyte Subtypes (1)
257147 101
935
507397
0
200
400
600
800
1000
1200
1400
1600
CD3+ CD4+ CD8+
Dead
Alive
T Lymphocyte Subtypes (2)
Chest X-ray
Interstitial damage 184 (70.7%)
Small patch-like or spotty shadow 195 (75%)
Large patch-like shadow 161 (61.9%)
Reticular opacities 93 (35.8%)
Both lung involvement 192 (73.8%)
Management
• Oxygen taking
• Antibiotics: empirically
• Anti-viral reagents : Ribavirin
• Glucocorticoid (Methyprednisolone)
• Artificial Ventilator support
Corticosteroid Management
Early systemic corticosteroid administrationAutopsy showed: hyalinization of airway basal membrane, alveolar fibrosis (similar to ARDS)
Indication:
High fever>3 days
Chest X ray deteriorates progressively
Dose of methylprednisolone in Guangzhou No.8 Hosp
• Dose of MP 140±123mg/d (40~500mg/d)
• Duration 14±12 days
• N=54
No-invasive Positive Pressure Ventilation (CPAP/BiPAP)
Indications:
1. RR>30times/min ;
2.SaO2< 93% when taking
oxygen 3-5L/min
3 、 Difficulty in breathing
No.8 Hosp. N=54/262
Average time of hospitalization
Common type 13.8 ± 3.5 d
Severe type 28.4 ± 10.3 d
Fatality rate 4.2% (12/260)
Prognosis
Mortality in Guangzhou
Total cases 1274
Dead 46 3.61%
70% (892 cases) with IgG titer 4 times higher than normal
Mortality 46/892 = 5.16%5.16%
Low mortality in Guangdong (why?) (1)
• Misdiagnosis
• Less worse epidemics
– Peak < 60 newly diagnosed pts/day
• Age distribution ?
• Fewer patients with underlying diseases?
Low mortality in Guangdong (why?) (2)
• Critical Cases
• Medical staff
• Guideline - better efficacy with combined man
agement (lower dose corticosteroid +CPAP/Bi
PAP)
referred to well-equipped referred to well-equipped
and well-trained hospitalsand well-trained hospitals
Distribution of death relating to age (n=931)
Age
(yrs)<15 15-20 20-30 30-40 40-50 50-60 60-70 >70 Total
Case 12 47 287 255 161 82 50 37 931
Death 0 0 1 5 13 5 7 4 35
% 0 0 0.4 2.0 8.1 6.1 14 11 3.7
Underlying Disease relating to death (n=931)
Total With underlying disease
No underlying disease
Case 931 190 (20.4%) 741 (79.6%)
Death 35 15 20
% 3.7 7.9 2.7
Underlying diseases—Diabetes, COPD, chronic asthma, cancer, chronic renal disease, hypertension, pulmonary TB, chronic hepatitis, chronic heart failure, etc
A comparison of Intubation Rate and Crude Fatality Rate in SARS patients
NNCPAPCPAP
(BiPAP)(BiPAP)IntubationIntubation FatalityFatality
Hong Kong 175535
(2.0%)
246
(14.0%)
300
(17.1%)
Guangzhou 528122
(23.1%)
39
(7.4%)
29
(5.5%)
P
(X2 test)
<0.001
(228.3)
<0.001
(16.3)
<0.001
(43.6)
Number Of SARS Patients and HCW Infection (AS of 8/7/2003) Cases Death (%) HCW(%) Last Report
Global 8422 916 11 1725(20) 7.13
China(Main) 5327 349 7 1002(19) 6.25
Guangdong 1512 58 4 346(23) 6.25
Hongkong 1755 300 17 386(22) 5.31
Taiwan 665 180 27 86(13) 6.15Canada 251 41 17 108(43) 6.12Singapore 283 33 14 97(41) 5.05
Medical Staff Infection in Our Hospital
• Total 20 (8 doctors, 12 nurses)
• Happened during the time when there
were most patients ( from Feb. 12 to
Feb.19 )
• All recovered
top related